drugset / Trial / NCT00802087

Single Dose Pharmacokinetics of Egalet® Hydrocodone

NCT00802087

Phase 1 Completed 28 enrolled Egalet Ltd
RandomizedCrossoverOpen-label

Summary

The purpose of the study is to evaluate the pharmacokinetic profile of different Egalet® hydrocodone formulations and compare to a marketed hydrocodone drug.

Timeline

Start
2008-11
Primary completion
2008-12
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule
Comparator Hydrocodone Unknown

Indications

No indication recorded.